Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Masuda

Showing results (241-250 of 249) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 249 results.
International Urology and Nephrology|April 21, 2026
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinationsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2021
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomyNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
European Urology Focus|July 21, 2017
Ureteral Involvement Is Associated with Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma Patients Treated by Nephroureterectomy: A Multicenter Database StudyYuma Waseda, Kazutaka Saito, Junichiro Ishioka, et al.
World Journal of Urology|March 21, 2024
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysisNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2014
Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter studyHiroshi Fukushima, Kazutaka Saito, Junichiro Ishioka, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Lancet. Oncology|July 11, 2026
Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trialAkihiro Ito, Yoichi Arai, Yoshiyuki Kakehi, et al.
Anticancer Research|October 3, 2014
Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patientsJunichiro Ishioka, Hitoshi Masuda, Toshiki Kijima, et al.
BJU International|March 12, 2014
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomyJunichiro Ishioka, Kazutaka Saito, Toshiki Kijima, et al.
Pageof 25

Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
International Urology and Nephrology|April 21, 2026
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinationsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2021
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomyNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
European Urology Focus|July 21, 2017
Ureteral Involvement Is Associated with Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma Patients Treated by Nephroureterectomy: A Multicenter Database StudyYuma Waseda, Kazutaka Saito, Junichiro Ishioka, et al.
World Journal of Urology|March 21, 2024
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysisNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2014
Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter studyHiroshi Fukushima, Kazutaka Saito, Junichiro Ishioka, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Lancet. Oncology|July 11, 2026
Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trialAkihiro Ito, Yoichi Arai, Yoshiyuki Kakehi, et al.
Anticancer Research|October 3, 2014
Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patientsJunichiro Ishioka, Hitoshi Masuda, Toshiki Kijima, et al.
BJU International|March 12, 2014
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomyJunichiro Ishioka, Kazutaka Saito, Toshiki Kijima, et al.
Pageof 25